Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Sponsored By: Representative DeGette, Diana [D-CO-1]
Introduced
Summary
No summary available.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
DeGette, Diana [D-CO-1]
CO • D
Cosponsors
Rep. Pressley, Ayanna [D-MA-7]
MA • D
Sponsored 5/14/2026
McClellan
VA • D
Sponsored 5/14/2026
Clark (MA)
MA • D
Sponsored 5/14/2026
Rep. Bell, Wesley [D-MO-1]
MO • D
Sponsored 5/14/2026
Rep. Tonko, Paul [D-NY-20]
NY • D
Sponsored 5/14/2026
Rep. García, Jesús G. "Chuy" [D-IL-4]
IL • D
Sponsored 5/14/2026
Rep. Velázquez, Nydia M. [D-NY-7]
NY • D
Sponsored 5/14/2026
Rep. Moulton, Seth [D-MA-6]
MA • D
Sponsored 5/14/2026
Rep. Pettersen, Brittany [D-CO-7]
CO • D
Sponsored 5/14/2026
Del. Norton, Eleanor Holmes [D-DC-At Large]
DC • D
Sponsored 5/14/2026
Rep. Balint, Becca [D-VT-At Large]
VT • D
Sponsored 5/14/2026
Rep. Dexter, Maxine [D-OR-3]
OR • D
Sponsored 5/14/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov